VolitionRX Stock Forecast
NYSE: VNRXHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
VNRX analyst consensus
Consensus (5 analysts)
none
Avg. price target
$13.62+6107.84%
- Strong buy 1
- Buy 3
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 5 Wall Street analysts covering VolitionRX (2026-10-09), 4 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $13.62, with a high estimate of $24.00 and a low estimate of $2.00. The average target implies upside of 6107.8% from the current price of $0.2194.
The spread between the highest and lowest targets is 1100.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for VNRX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 20% |
| Buy | 3 | 60% |
| Hold | 1 | 20% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $2.00 | +811.58% |
| Average target | $13.62 | +6107.84% |
| High target | $24.00 | +10838.92% |